These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 38966586)
1. HPV status and immunohistochemical analysis of p16, p53 and PD‑L1 expression as prognostic biomarkers in patients with squamous cell anal cancer receiving definitive radiotherapy/chemoradiotherapy. Balci Topuz B; Sert F; Sezak M; Soylu M; Yalman D; Ozkok S Oncol Lett; 2024 Aug; 28(2):395. PubMed ID: 38966586 [TBL] [Abstract][Full Text] [Related]
2. A Systematic Review and Meta-Analysis of Prognostic Biomarkers in Anal Squamous Cell Carcinoma Treated With Primary Chemoradiotherapy. Parwaiz I; MacCabe TA; Thomas MG; Messenger DE Clin Oncol (R Coll Radiol); 2019 Dec; 31(12):e1-e13. PubMed ID: 31301958 [TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy. Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of HPV status and p16 expression in patients with carcinoma of the anal canal. Roldán Urgoiti GB; Gustafson K; Klimowicz AC; Petrillo SK; Magliocco AM; Doll CM PLoS One; 2014; 9(10):e108790. PubMed ID: 25271758 [TBL] [Abstract][Full Text] [Related]
5. Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status. Zhu X; Jamshed S; Zou J; Azar A; Meng X; Bathini V; Dresser K; Strock C; Yalamarti B; Yang M; Tomaszewicz K; Tjionas G; Mochel MC; Hutchinson L; Bledsoe JR Mod Pathol; 2021 May; 34(5):1017-1030. PubMed ID: 33483624 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Human Papilloma Virus and p16 Expression in Patients with Vulvar Squamous Cell Carcinoma who Received Radiotherapy. Yap ML; Allo G; Cuartero J; Pintilie M; Kamel-Reid S; Murphy J; Mackay H; Clarke B; Fyles A; Milosevic M Clin Oncol (R Coll Radiol); 2018 Apr; 30(4):254-261. PubMed ID: 29449057 [TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy. Yhim HY; Lee NR; Song EK; Kwak JY; Lee ST; Kim JH; Kim JS; Park HS; Chung IJ; Shim HJ; Hwang JE; Kim HR; Nam TK; Park MR; Shim H; Park HS; Kim HS; Yim CY Int J Cancer; 2011 Oct; 129(7):1752-60. PubMed ID: 21128253 [TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on Cancer stages I to III carcinoma of the anal canal. Serup-Hansen E; Linnemann D; Skovrider-Ruminski W; Høgdall E; Geertsen PF; Havsteen H J Clin Oncol; 2014 Jun; 32(17):1812-7. PubMed ID: 24821878 [TBL] [Abstract][Full Text] [Related]
9. Prognostic importance of human papillomavirus (HPV) and p16 positivity in squamous cell carcinoma of the vulva treated with radiotherapy. Lee LJ; Howitt B; Catalano P; Tanaka C; Murphy R; Cimbak N; DeMaria R; Bu P; Crum C; Horowitz N; Matulonis U; Viswanathan AN Gynecol Oncol; 2016 Aug; 142(2):293-8. PubMed ID: 27210818 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of human papillomavirus in anal squamous cell carcinoma. Ravenda PS; Magni E; Botteri E; Manzotti M; Barberis M; Vacirca D; Trovato CM; Dell'Acqua V; Leonardi MC; Sideri M; Fazio N; Zampino MG Cancer Chemother Pharmacol; 2014 Nov; 74(5):1033-8. PubMed ID: 25209946 [TBL] [Abstract][Full Text] [Related]
11. HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer. Meyer JE; Panico VJ; Marconato HM; Sherr DL; Christos P; Pirog EC J Gastrointest Cancer; 2013 Dec; 44(4):450-5. PubMed ID: 24014082 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of HPV-PCR, p16 and p53 immunohistochemical status on local recurrence rate and survival in patients with vulvar squamous cell carcinoma. Pouwer AW; Te Grootenhuis NC; Hinten F; de Bock GH; van der Zee AGJ; Melchers WJG; Oonk MHM; de Hullu JA; Hollema H; Bulten J Virchows Arch; 2024 Jun; 484(6):985-994. PubMed ID: 37938322 [TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smoking. Lilja-Fischer JK; Eriksen JG; Georgsen JB; Vo TT; Larsen SR; Cheng J; Busch-Sørensen M; Aurora-Garg D; Steiniche T; Overgaard J Acta Oncol; 2020 Jun; 59(6):666-672. PubMed ID: 32079442 [No Abstract] [Full Text] [Related]
15. Different protein expression associated with chemotherapy response in oropharyngeal cancer according to HPV status. Kim MJ; Ki MS; Kim K; Shim HJ; Hwang JE; Bae WK; Chung IJ; Lee DH; Lee JK; Yoon TM; Lim SC; Chung WK; Jeong JU; Lim HS; Choi YD; Cho SH BMC Cancer; 2014 Nov; 14():824. PubMed ID: 25380690 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell Anal Cancer. Mai S; Welzel G; Ottstadt M; Lohr F; Severa S; Prigge ES; Wentzensen N; Trunk MJ; Wenz F; von Knebel-Doeberitz M; Reuschenbach M Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):819-27. PubMed ID: 26530750 [TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma. Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365 [TBL] [Abstract][Full Text] [Related]
18. Significance of HPV16 Viral Load Testing in Anal Cancer. Małusecka E; Chmielik E; Suwiński R; Giglok M; Lange D; Rutkowski T; Mazurek AM Pathol Oncol Res; 2020 Oct; 26(4):2191-2199. PubMed ID: 32266586 [TBL] [Abstract][Full Text] [Related]
19. High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: different implications for vaccine prevention and prognosis. Baricevic I; He X; Chakrabarty B; Oliver AW; Bailey C; Summers J; Hampson L; Hampson I; Gilbert DC; Renehan AG Eur J Cancer; 2015 Apr; 51(6):776-85. PubMed ID: 25702585 [TBL] [Abstract][Full Text] [Related]
20. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group. Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]